619P Maintenance versus discontinuation of androgen deprivation therapy during docetaxel administration with a continuous or an intermittent schedule in metastatic, castration resistant, prostate cancer patients: A multicenter randomized phase III study of the Piemonte Oncology Network

Autor: Berruti, A., Mosca, A., Bianchi, S., Prati, V., Ortega, C., Buttigliero, C., Fea, E., Vanella, P., Valcamonico, F., Ciccone, G., Sirotova, Z., Chiappino, I., Canton, O. Dal, Masini, C., Sacco†, C., Amoroso, D., Montagnani, F., Comandone, A., Gennari, A., Tucci, M.
Zdroj: In Annals of Oncology September 2020 31 Supplement 4:S512-S512
Databáze: ScienceDirect